Yulin Deng Selected Research

salsolinol

3/2022	Sal synthase induced cytotoxicity of PC12 cells through production of the dopamine metabolites salsolinol and N-methyl-salsolinol.
1/2018	Changes in salsolinol production and salsolinol synthase activity in Parkinson's disease model.
5/2015	Salsolinol Damaged Neuroblastoma SH-SY5Y Cells Induce Proliferation of Human Monocyte THP-1 Cells Through the mTOR Pathway in a Co-culture System.
11/2014	Methylglyoxal increases dopamine level and leads to oxidative stress in SH-SY5Y cells.
3/2013	Increased vulnerability of parkin knock down PC12 cells to hydrogen peroxide toxicity: the role of salsolinol and NM-salsolinol.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yulin Deng Research Topics

Disease

18	Parkinson Disease (Parkinson's Disease) 03/2022 - 10/2008
17	Neoplasms (Cancer) 05/2022 - 10/2009
8	Alzheimer Disease (Alzheimer's Disease) 03/2019 - 01/2012
6	Neoplasm Metastasis (Metastasis) 05/2022 - 07/2015
5	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2021 - 08/2011
5	Type 2 Diabetes Mellitus (MODY) 01/2021 - 11/2013
5	Glioma (Gliomas) 01/2020 - 08/2011
4	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2020
4	Neuroblastoma 03/2019 - 02/2013
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 10/2019
3	Neuroinflammatory Diseases 11/2021 - 05/2015
3	Brain Neoplasms (Brain Tumor) 01/2021 - 11/2015
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018 - 01/2017
3	Body Weight (Weight, Body) 02/2013 - 01/2008
2	Hyperglycemia 02/2019 - 04/2015
2	Melanoma (Melanoma, Malignant) 01/2018 - 01/2018
2	Pathologic Processes 01/2016 - 03/2015
2	Experimental Melanoma 10/2011 - 08/2008
2	Edema (Dropsy) 02/2010 - 08/2007
1	Major Depressive Disorder (Major Depressive Disorders) 01/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2021
1	Hypoxia (Hypoxemia) 06/2021
1	Triple Negative Breast Neoplasms 05/2021
1	Diabetes Mellitus 01/2021
1	Fever (Fevers) 01/2021
1	Dengue (Dengue Fever) 01/2021
1	Infections 01/2021
1	Brain Injuries (Brain Injury) 08/2020
1	Obesity 01/2020
1	Overweight 01/2020
1	Disease Progression 01/2020
1	Inflammation (Inflammations) 10/2019
1	Insulin Resistance 02/2019
1	Bacterial Infections (Bacterial Infection) 09/2018
1	Leukemia 03/2018
1	Glucose Metabolism Disorders 11/2017

Drug/Important Bio-Agent (IBA)

13	NeurotoxinsIBA 03/2022 - 03/2013
10	Proteins (Proteins, Gene)FDA Link 11/2021 - 06/2012
6	SynucleinsIBA 01/2022 - 08/2011
5	salsolinolIBA 03/2022 - 03/2013
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2014
5	Pharmaceutical PreparationsIBA 01/2020 - 01/2008
4	Dopamine (Intropin)FDA LinkGeneric 01/2018 - 03/2013
3	Mechanistic Target of Rapamycin Complex 1IBA 05/2022 - 01/2018
3	MicroRNAs (MicroRNA)IBA 01/2022 - 05/2019
3	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 11/2021 - 04/2012
3	Peptides (Polypeptides)IBA 01/2021 - 08/2008
3	Biological ProductsIBA 01/2021 - 03/2015
3	Amyloid (Amyloid Fibrils)IBA 03/2019 - 06/2012
2	LipidsIBA 06/2021 - 03/2019
2	Glycerolphosphate Dehydrogenase (Glycerol 3 Phosphate Dehydrogenase)IBA 06/2021 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2021 - 09/2014
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 04/2004
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 04/2016
2	ProteomeIBA 06/2020 - 11/2017
2	Amine Oxidase (Copper-Containing)IBA 04/2020 - 01/2020
2	Hypoglycemic Agents (Hypoglycemics)IBA 04/2020 - 02/2019
2	EnzymesIBA 01/2020 - 11/2017
2	GlycosidesIBA 03/2018 - 07/2017
2	Dimethylnitrosamine (Nitrosodimethylamine)IBA 11/2017 - 01/2017
2	Therapeutic UsesIBA 03/2016 - 10/2011
2	Glycoproteins (Glycoprotein)IBA 07/2015 - 03/2015
2	Conditioned Culture MediaIBA 05/2015 - 06/2014
2	1,2,3,4-tetrahydroisoquinolineIBA 04/2015 - 02/2013
2	alpha-SynucleinIBA 06/2013 - 12/2009
2	Interleukin-2 (IL2)IBA 01/2013 - 10/2011
2	Acetic Acid (Vinegar)FDA LinkGeneric 02/2010 - 08/2007
2	Xylenes (Xylene)IBA 02/2010 - 08/2007
1	Focal Adhesion Protein-Tyrosine KinasesIBA 05/2022
1	E2F Transcription FactorsIBA 01/2022
1	GlycogenIBA 06/2021
1	CytokinesIBA 05/2021
1	MicellesIBA 05/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 01/2021
1	CreatineIBA 04/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Citrate (si)-Synthase (Synthase, Citrate)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Free RadicalsIBA 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2020
1	InflammasomesIBA 10/2019
1	Hydroxyl RadicalIBA 03/2019
1	ChalconesIBA 03/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2019
1	Insulin (Novolin)FDA Link 02/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2018
1	LignansIBA 01/2018
1	IntegrinsIBA 01/2018
1	Oxidopamine (6 Hydroxydopamine)IBA 01/2018
1	SaponinsIBA 01/2018
1	TriterpenesIBA 01/2018
1	AcidsIBA 11/2017
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2017
1	InterleukinsIBA 07/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2017

Therapy/Procedure

13	Therapeutics 06/2021 - 01/2012
4	Radiotherapy 01/2021 - 10/2009
2	Immunotherapy 10/2011 - 10/2009